期刊文献+

原位杂交法检测MDR1基因在食管癌中的表达及与p53的关系 被引量:2

Expression of MDR1mRNA detected and its correlation with p53 in esophageal carcinoma by in situ hybridization
下载PDF
导出
摘要 目的:了解食管癌组织MDR1基因表达的临床意义及其与p53的关系。方法:用原位杂交法检测了57例食管癌组织标本中MDR1基因的表达,免疫组化法检测了其中44例p53蛋白的表达并进行临床病理分析及相关性分析。结果:57例食管癌组织中MDR1mRNA阳性表达率为35%(20/57),其中食管癌无淋巴结转移的患者阳性表达为29%(8/29),有淋巴结转移患者阳性表达分别为41%(12/28),高于无淋巴结转移患者的表达。临床Ⅱ期食管癌患者阳性表达分别为27%(8/30),临床Ⅲ-Ⅳ期阳性表达为44%(12/27),高于临床Ⅱ期患者的表达。食管癌患者MDR1mRNA表达与肿瘤大小、部位、分化程度、肿瘤浸润的程度无明显相关。44例食管癌组织中p53蛋白阳性表达率为73%(32/44),其中食管癌浸润至肌层,p53表达率为45%(5/11),肿瘤浸润至外膜,p53表达率为82%(27/33),差异有显著性,P<0.01。食管癌患者p53表达与肿瘤大小、部位、分化程度、有无淋巴结转移、临床分期无明显相关。32例p53蛋白表达阳性的组织中有10例MDR1mRNA表达阳性,它们之间的表达在统计学上无明显相关。结论:MDR1基因及突变型p53在食管癌组织中均有过表示,其表达可能与食管癌进展相关。在食管癌组织中MDR1基因表达可能并非受p53的调控。 Objective To explore the clinical significance of multidrug resistance (MDR1) expression and its correlation with P 53 in esophageal carcinoma.Methods The expression of MDR1 by in situ hybridization in 57 esophageal carcinomas and the expression of P 53 by immunohistochemistry in 44 of 57 esophageal carcinomas were analyzed,and then evaluated their relationship with clinicopathological factors and their correlation.Results The positive expression rate of MDR1mRNA was 35%in 57 esophageal carcinomas.Eight positive expression cases (29%) were found in 28 cases without lymph node metastasis,and 12 positive expression cases (41%) were found in 29 cases with lymph node metastasis;Eight positive expression cases (27%) were found in 30 clinical II stage cases,and 12 positive expression cases (44%) were found in 27 clinical III-IV stage cases.No significant correlation was found among MDR1mRNA expression and tumor size,position,differentiation degree and infiltration degree.The positive expression rate of mutation P 53 was 73%in 44 esophageal carcinomas.Five positive expression cases (45%) were found in 11 cases that tumor cells invaded to muscle,and 27 positive expression cases (41%) were found in 33 cases that tumor cells invaded to serous membrane.Significant difference between them was found(P< 0.01).No significant correlation was found among mutation P 53 expression and tumor size,position,differentiation degree,lymph node metastasis state and clinical stage.Ten MDR1mRNA positive expression cases were found in 32 P 53 positive expression cases,no significant correlation between them(P< 0.01).Conclusion Over expressions of MDR1mRNA and mutation P 53 were significantly associated with esophageal carcinoma progression.The expression of MDR1mRNA might not be regulated by mutation P 53.
出处 《实用医学杂志》 CAS 2005年第9期900-902,共3页 The Journal of Practical Medicine
基金 浙江省医药卫生科研基金资助(No:2000A017)
关键词 原位杂交法 检测 MDR1基因 食管癌 表达 P53 Esophageal neoplasms Genes,MDR In situ hybridization Protein P 53
  • 相关文献

参考文献14

  • 1许沈华.多药耐药性检测的临床意义[J].中国肿瘤,1999,8(9):421-422. 被引量:5
  • 2许沈华 凌雨田 朱赤红 等.用FCM检测食管癌细胞P-糖蛋白表达的临床意义[J].中华实用医药杂志,2003,3(19):1750-1753.
  • 3职锦洲,李秀梅,李秀杰,杨廷桐.食管癌及癌旁正常组织中p53、mdr基因表达的临床意义[J].国外医学(临床生物化学与检验学分册),2003,24(3):178-179. 被引量:2
  • 4MM Gottesman.How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.Cancer Res, 1993, 53(4): 747-754
  • 5许沈华,倪型灏,凌雨田,张谷,朱赤红,刘祥麟.食管癌细胞中c-erbB-2与P-gp表达的相关性[J].临床与实验病理学杂志,2004,20(2):203-205. 被引量:7
  • 6W Cao, X Chen, H Dai, et al.Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China.Cancer, 2004, 101(4): 834-844
  • 7Chin KV, Ueda K, Pastan I, et al.Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.Science, 1992, 255(5043): 459-462
  • 8Bahr, W.Wick, M.Weller.Modulation of MDR/MRP by wild-type and mutant p53.J.Clin.Invest, 2001, 107(5): 643-645
  • 9Renninson J, Baker BW, McGown AT, et al.Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical features.Br J Cancer, 1994, 69(3): 609-612
  • 10Y Soini, N Virkajarvi, H Raunio, et al.Expression of P-glycoprotein in hepatocellular carcinoma: a potential marker of prognosis.J Clin Pathol, 1996, 49(6): 470-473

二级参考文献20

  • 1冯晓莉,张学兵,万云霞,马建辉,孙耘田.肾细胞癌中c-erbB-2表达及其意义[J].临床与实验病理学杂志,2003,19(2):177-180. 被引量:2
  • 2Stenunermann G, Heffelfinger SC, Noffsinger A, et al. The molecular biology of esophageal and gastric cancer and their precursors:oncogenes, tumor suppressor genes and growth factors[J]. Hum Pathol,1994,25:968.
  • 3Musto P. High risk of early resistance relaps for leukemic patients with presence of multidrug resistance assosiated glycoprotein positive cells in complete remission[J]. Br J Haematol, 1991,77:50 .
  • 4Levin A J, Momand J. Finlay CA. The p53 tumor suppressor gene[J]. Nature, 1991,351:453.
  • 5Parenti AR, Rugge M, Frizzera E, et al. p53 overexpression in the multistep process of esophageal carcinogenesis[J]. Am J SurgPathol, 1995,19:1418.
  • 6Fehm T, Gebauer G, Jager W, et al . Clinical utility of serial serum c-erbB-2 determinations in the follow-up of breast cancer patients. Breast Cancer Res Treat, 2002,75(2) :97~106.
  • 7Santin AD, Bellone S, Gokden M, et al. Overexpression of HER-2/neu in uterine serous papillary cancer. Clin Cancer Res,2002,8(5) :1271~9.
  • 8Kono K, Takahashi A, Ichihara F, et al. Impaired antibodydependent cellular cytotoxicity mediated by herceptin in patients with gastric cancer. Cancer Res, 2002,62 (20) :5813~7.
  • 9Lam KY,Tin L,Ma L,etal. c-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas with special reference to histological grade of carcinoma and pre-invasive lesions. EurJ Surg Oncol ,1998,24(5):431~5.
  • 10许沈华.多药耐药性检测的临床意义[J].中国肿瘤,1999,8(9):421-422. 被引量:5

共引文献12

同被引文献119

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部